Daytime Sinus Capsule, Liquid Filled
NDC Package 53345-030-01
Package Information
Daytime Sinus (acetaminophen, phenylephrine hydrochloride) capsules is take only as directed - see Overdose warningdo not exceed 4 doses per 24 hoursadults and children 12 years of age and over take 2 softgels with water every 4 hourschildren 4 to under 12 years of age ask a doctorchildren under 4 years of agedo not usewhen using other Daytime or Nighttime products, carefully read each label to insure correct dosing. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Humanwell Puracap Pharmaceutical (wuhan) Co., Ltd., this product is identified by NDC 53345-030 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1052670 - acetaminophen 325 MG / phenylephrine HCl 5 MG Oral Capsule
- RxCUI: 1052670 - acetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule
- RxCUI: 1052670 - APAP 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 53345 - Humanwell Puracap Pharmaceutical (wuhan) Co., Ltd.
- 53345-030 - Daytime Sinus
- 53345-030-01 - 1 BAG in 1 BOX / 4000 CAPSULE, LIQUID FILLED in 1 BAG
- 53345-030 - Daytime Sinus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53345-030-01 identifies a specific commercial package of 1 bag in 1 box / 4000 capsule, liquid filled in 1 bag of Daytime Sinus, a human over the counter drug labeled by Humanwell Puracap Pharmaceutical (wuhan) Co., Ltd.. This capsule, liquid filled is formulated for oral use and contains acetaminophen; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Humanwell Puracap Pharmaceutical (wuhan) Co., Ltd. on February 26, 2015. The current certification is valid through December 31, 2026.
How is this Humanwell Puracap Pharmaceutical (wuhan) Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53345003001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.